FDA NDC Directory · JSON-LD · Markdown

LEMTRADA

NDC 58468-0200 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION, CONCENTRATE

Generic nameALEMTUZUMAB
Labeler / ManufacturerGenzyme Corporation
Marketing categoryBiologic License Application · App BLA103948
Dosage form / routeINJECTION, SOLUTION, CONCENTRATE · INTRAVENOUS
Active ingredientsALEMTUZUMAB (12 mg/1.2mL)
Marketing started20141118
Package count1

External sources

Source: openFDA. Public-domain (CC0).